Knives out for FDA head Marty Makary after he blocks, then OKs vape flavors

Key Points:

• FDA Commissioner Dr. Marty Makary faces mounting criticism from various groups, including anti-abortion activists and some administration officials, after President Trump pressured him to approve flavored e-cigarettes with new age-verification technology.
• The controversy stems from Makary's initial blocking of flavored vape approvals, which conflicted with Trump's 2024 campaign promise to support the vaping industry, leading to accusations that Makary undermined the president's stance.
• Additional criticisms target Makary's decisions on abortion pill distribution, funding a socially progressive charter school, and his staffing choices, reflecting broader tensions within the administration over his policy directions.
• Despite internal opposition, Makary has aligned with some of Trump's priorities, such as easing psychedelic therapies and speeding drug approvals, while contending with lobbying pressures and maintaining a cautious approach on youth vaping concerns.
• The situation underscores the challenges Makary faces navigating political dynamics and fulfilling presidential expectations amid divisive public health and social issues within the FDA and the broader administration.